# Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Buccal Screening Evaluation Using an RT-PCR Assay and a Rapid ELISA Test Among Symptomatic and Asymptomatic Patients

> **NCT05074745** · NA · UNKNOWN · sponsor: **Centre Scientifique de Monaco** · enrollment: 1500 (estimated)

## Conditions studied

- SARS-CoV-2
- COVID-19

## Interventions

- **DIAGNOSTIC_TEST:** ELISA POCT vs RT-PCR

## Key facts

- **NCT ID:** NCT05074745
- **Lead sponsor:** Centre Scientifique de Monaco
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-02-18
- **Primary completion:** 2021-12-30
- **Final completion:** 2021-12-30
- **Target enrollment:** 1500 (ESTIMATED)
- **Last updated:** 2021-10-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05074745

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05074745, "Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Buccal Screening Evaluation Using an RT-PCR Assay and a Rapid ELISA Test Among Symptomatic and Asymptomatic Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05074745. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*